{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:36:23Z","timestamp":1768811783209,"version":"3.49.0"},"reference-count":8,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T00:00:00Z","timestamp":1266796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:italic>Please cite this paper as:<\/jats:italic> Chappell L, Seed P, Enye S, Briley A, Poston L, Shennan A. Clinical and geographical variation in prophylactic and therapeutic treatments for pre\u2010eclampsia in the UK. BJOG 2010; DOI: 10.1111\/j.1471\u20100528.2010.02507.x.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To evaluate the clinical and geographical variation in the use of aspirin in women at high risk of pre\u2010eclampsia, and in the use of antihypertensive drugs and magnesium sulphate in women with established pre\u2010eclampsia.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Analysis of vitamins in pre\u2010eclampsia (VIP) trial database.<\/jats:p><jats:p><jats:bold>Sample\u2002<\/jats:bold> A total of 2399 women at increased risk of pre\u2010eclampsia in 25 UK hospitals.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> An analysis of a large prospectively validated database of high\u2010risk women in the UK was undertaken to assess aspirin use across different risk groups and to evaluate the use of antihypertensives and magnesium sulphate in 370 women who developed pre\u2010eclampsia. Logistic regression was employed to compare drug use between region and by recognised clinical indicators.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> Usage of aspirin, antihypertensive drugs and magnesium sulphate.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of the women with known risk factors at trial entry, 24% (569\/2399) received low\u2010dose aspirin. Aspirin usage varied widely between risk groups [from 5% (19\/378) in women with multiple pregnancy to 94% (50\/53) in women with antiphospholipid syndrome] and between geographical regions [from 8% (20\/248) to 49% (95\/193)]. Three hundred and seventy women developed pre\u2010eclampsia, 52% (<jats:italic>n<\/jats:italic>\u2003=\u2003193) of whom received new or additional antihypertensives after 20\u2003weeks of gestation; 34% (77\/224) with a maximum recorded systolic blood pressure of \u2265160\u2003mmHg in the second half of pregnancy did not receive antihypertensive treatment; 17% (62\/370) of women with pre\u2010eclampsia received magnesium sulphate prophylactically.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Prophylactic and treatment regimes for pre\u2010eclampsia in the UK vary by region and risk group.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2010.02507.x","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T11:02:42Z","timestamp":1266836562000},"page":"695-700","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and geographical variation in prophylactic and therapeutic treatments for pre\u2010eclampsia in the UK"],"prefix":"10.1111","volume":"117","author":[{"given":"LC","family":"Chappell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Seed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Enye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AL","family":"Briley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Poston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AH","family":"Shennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"key":"e_1_2_11_2_2","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre\u2010eclampsia and its complications","volume":"2","author":"Duley L","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_3_2","first-page":"CD000025","article-title":"Magnesium sulphate and other anticonvulsants for women with pre\u2010eclampsia","volume":"2","author":"Duley L","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002252"},{"key":"e_1_2_11_5_2","volume-title":"The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers\u2019 Lives: Reviewing Maternal Deaths to Make Motherhood Safer \u2013 2003\u20132005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom","author":"Lewis G","year":"2007"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68433-X"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60712-0"},{"key":"e_1_2_11_8_2","volume-title":"Management of Severe Pre\u2010eclampsia\/Eclampsia","author":"Royal College of Obstetricians and Gynaecologists (RCOG)","year":"2006"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01423.x"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2010.02507.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2010.02507.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:02:29Z","timestamp":1698760949000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2010.02507.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1471-0528.2010.02507.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02507.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,8]]},"assertion":[{"value":"2010-04-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}